Sivik Global Healthcare LLC Buys Eli Lilly and Co, Catalent Inc, Abbott Laboratories, Sells Smith & Nephew PLC, Hill-Rom Holdings Inc, Incyte Corp

• New Purchases: LLY, CTLT, UHS, UNH, BAX, BSX, CRL, IQV, EHC, GH, BIO, NUVA,
• Added Positions: ABT, JNJ, ZBH, MOH, ABC, MCK, PPD, AVTR, MDT,
• Reduced Positions: DGX, HUM, BMRN, SYK, HCA, DHR, LH, TMO, REGN, CNC, LHCG, AMED, MRK, OMI, BIIB, SEM, BDX,
• Sold Out: SNN, HRC, INCY, NVO, ISRG, CAH, CI, ABBV, HOLX, VRTX, NVRO, GILD, THC, BMY, ILMN, TEVA, AMRX, BNTX, ADPT, CRSP, BLUE, AGIO, CNST, EIGR,

For the details of Sivik Global Healthcare LLC's stock buys and sells, go to https://www.gurufocus.com/guru/sivik+global+healthcare+llc/current-portfolio/portfolio

1. Abbott Laboratories (ABT) - 90,000 shares, 4.21% of the total portfolio. Shares added by 260.00%
2. Danaher Corp (DHR) - 45,000 shares, 4.17% of the total portfolio. Shares reduced by 43.75%
3. Johnson & Johnson (JNJ) - 60,000 shares, 3.84% of the total portfolio. Shares added by 100.00%
4. Thermo Fisher Scientific Inc (TMO) - 20,000 shares, 3.80% of the total portfolio. Shares reduced by 81.14%
5. Humana Inc (HUM) - 20,000 shares, 3.56% of the total portfolio. Shares reduced by 70.37%

Sivik Global Healthcare LLC initiated holding in Eli Lilly and Co. The purchase prices were between $146.22 and $169.13, with an estimated average price of $154.85. The stock is now traded at around $142.38. The impact to a portfolio due to this purchase was 3.5%. The holding were 55,000 shares as of .

Sivik Global Healthcare LLC initiated holding in Catalent Inc. The purchase prices were between $72.74 and $92.5, with an estimated average price of $84.37. The stock is now traded at around $104.61. The impact to a portfolio due to this purchase was 3.41%. The holding were 92,500 shares as of .

Sivik Global Healthcare LLC initiated holding in Universal Health Services Inc. The purchase prices were between $88.61 and $122.03, with an estimated average price of $106.86. The stock is now traded at around $133.20. The impact to a portfolio due to this purchase was 2.99%. The holding were 65,000 shares as of .

Sivik Global Healthcare LLC initiated holding in UnitedHealth Group Inc. The purchase prices were between $291.16 and $323.7, with an estimated average price of $307.11. The stock is now traded at around $355.67. The impact to a portfolio due to this purchase was 2.95%. The holding were 22,000 shares as of .

Sivik Global Healthcare LLC initiated holding in Baxter International Inc. The purchase prices were between $78.33 and $90.73, with an estimated average price of $84.14. The stock is now traded at around $82.36. The impact to a portfolio due to this purchase was 2.94%. The holding were 85,000 shares as of .

Sivik Global Healthcare LLC initiated holding in Boston Scientific Corp. The purchase prices were between $34.44 and $42.23, with an estimated average price of $38.53. The stock is now traded at around $37.98. The impact to a portfolio due to this purchase was 2.79%. The holding were 170,000 shares as of .

Sivik Global Healthcare LLC added to a holding in Abbott Laboratories by 260.00%. The purchase prices were between $91.64 and $111.29, with an estimated average price of $101.35. The stock is now traded at around $112.60. The impact to a portfolio due to this purchase was 3.04%. The holding were 90,000 shares as of .

Sivik Global Healthcare LLC added to a holding in Johnson & Johnson by 100.00%. The purchase prices were between $140.38 and $153.83, with an estimated average price of $147.87. The stock is now traded at around $149.90. The impact to a portfolio due to this purchase was 1.92%. The holding were 60,000 shares as of .

Sivik Global Healthcare LLC added to a holding in Zimmer Biomet Holdings Inc by 120.00%. The purchase prices were between $117 and $145.93, with an estimated average price of $134.42. The stock is now traded at around $151.36. The impact to a portfolio due to this purchase was 1.76%. The holding were 55,000 shares as of .

Sivik Global Healthcare LLC added to a holding in Molina Healthcare Inc by 73.08%. The purchase prices were between $153.07 and $196.01, with an estimated average price of $181.96. The stock is now traded at around $219.74. The impact to a portfolio due to this purchase was 1.49%. The holding were 45,000 shares as of .

Sivik Global Healthcare LLC added to a holding in AmerisourceBergen Corp by 140.00%. The purchase prices were between $94.08 and $104.7, with an estimated average price of $99.36. The stock is now traded at around $108.12. The impact to a portfolio due to this purchase was 1.46%. The holding were 60,000 shares as of .

Sivik Global Healthcare LLC added to a holding in McKesson Corp by 61.54%. The purchase prices were between $140.89 and $159.9, with an estimated average price of $151.85. The stock is now traded at around $182.99. The impact to a portfolio due to this purchase was 1.28%. The holding were 52,500 shares as of .

Sivik Global Healthcare LLC sold out a holding in Smith & Nephew PLC. The sale prices were between $37.35 and $42.16, with an estimated average price of $40.24.

Sivik Global Healthcare LLC sold out a holding in Hill-Rom Holdings Inc. The sale prices were between $81.17 and $117.57, with an estimated average price of $97.98.

Sivik Global Healthcare LLC sold out a holding in Incyte Corp. The sale prices were between $85.07 and $109.69, with an estimated average price of $96.53.

Sivik Global Healthcare LLC sold out a holding in Novo Nordisk A/S. The sale prices were between $63.69 and $70.22, with an estimated average price of $66.63.

Sivik Global Healthcare LLC sold out a holding in Intuitive Surgical Inc. The sale prices were between $571.29 and $765.11, with an estimated average price of $673.15.

Sivik Global Healthcare LLC sold out a holding in Cardinal Health Inc. The sale prices were between $45.25 and $58.04, with an estimated average price of $51.3.